Highlighting a major shift at the FDA, regulators put Amicus' once-spurned drug on fast track
In general, the FDA’s fast track designations don’t make news. The majority of new drugs which gain approval these days get some sort of special …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
